Northpointe Capital LLC increased its holdings in shares of CME Group Inc (NASDAQ:CME) by 184.7% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,447 shares of the financial services provider’s stock after acquiring an additional 19,751 shares during the period. CME Group comprises approximately 1.6% of Northpointe Capital LLC’s holdings, making the stock its 18th largest holding. Northpointe Capital LLC’s holdings in CME Group were worth $5,011,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Dubuque Bank & Trust Co. boosted its position in CME Group by 83.1% in the 1st quarter. Dubuque Bank & Trust Co. now owns 152 shares of the financial services provider’s stock valued at $25,000 after buying an additional 69 shares during the last quarter. Resources Investment Advisors Inc. boosted its position in shares of CME Group by 2,800.0% in the 4th quarter. Resources Investment Advisors Inc. now owns 145 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 140 shares during the last quarter. Ruggie Capital Group bought a new position in shares of CME Group in the 4th quarter worth $28,000. Smith Asset Management Group LP boosted its position in shares of CME Group by 200.0% in the 4th quarter. Smith Asset Management Group LP now owns 150 shares of the financial services provider’s stock worth $28,000 after purchasing an additional 100 shares during the last quarter. Finally, Truvestments Capital LLC bought a new position in shares of CME Group in the 1st quarter worth $32,000. Institutional investors and hedge funds own 84.84% of the company’s stock.
In other CME Group news, Director Ronald A. Pankau sold 200 shares of CME Group stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $182.90, for a total value of $36,580.00. Following the sale, the director now owns 3,600 shares of the company’s stock, valued at approximately $658,440. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jeffrey M. Bernacchi sold 10,087 shares of CME Group stock in a transaction dated Tuesday, February 26th. The shares were sold at an average price of $177.94, for a total value of $1,794,880.78. Following the completion of the sale, the director now directly owns 42,004 shares in the company, valued at approximately $7,474,191.76. The disclosure for this sale can be found here. Insiders sold a total of 28,489 shares of company stock worth $4,948,996 in the last three months. Company insiders own 1.20% of the company’s stock.
Several research analysts have recently issued reports on CME shares. Bank of America set a $180.00 price target on CME Group and gave the stock a “hold” rating in a research report on Tuesday, April 9th. Sanford C. Bernstein restated an “outperform” rating and issued a $210.00 price target on shares of CME Group in a research report on Friday, February 15th. Zacks Investment Research lowered CME Group from a “hold” rating to a “sell” rating in a research report on Tuesday, April 9th. BidaskClub lowered CME Group from a “sell” rating to a “strong sell” rating in a research report on Friday, March 22nd. Finally, Jefferies Financial Group restated a “buy” rating and issued a $204.00 price target on shares of CME Group in a research report on Wednesday, January 9th. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and six have assigned a buy rating to the stock. CME Group presently has an average rating of “Hold” and an average target price of $192.00.
CME Group stock traded up $2.19 during mid-day trading on Wednesday, hitting $176.11. 450,209 shares of the company’s stock were exchanged, compared to its average volume of 1,638,254. The company has a market capitalization of $62.23 billion, a PE ratio of 25.82, a PEG ratio of 3.54 and a beta of 0.29. CME Group Inc has a fifty-two week low of $153.90 and a fifty-two week high of $197.08. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 0.15.
CME Group (NASDAQ:CME) last issued its quarterly earnings data on Thursday, February 14th. The financial services provider reported $1.77 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.75 by $0.02. CME Group had a return on equity of 9.85% and a net margin of 45.53%. The business had revenue of $1.24 billion for the quarter, compared to the consensus estimate of $1.22 billion. During the same quarter last year, the business posted $1.12 EPS. The firm’s revenue was up 37.4% compared to the same quarter last year. Analysts predict that CME Group Inc will post 6.81 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Monday, March 25th. Shareholders of record on Friday, March 8th were paid a $0.75 dividend. This is an increase from CME Group’s previous quarterly dividend of $0.70. The ex-dividend date was Thursday, March 7th. This represents a $3.00 annualized dividend and a dividend yield of 1.70%. CME Group’s dividend payout ratio (DPR) is currently 43.99%.
WARNING: “CME Group Inc (CME) Shares Bought by Northpointe Capital LLC” was posted by Modern Readers and is the property of of Modern Readers. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this report can be accessed at https://www.modernreaders.com/news/2019/04/17/cme-group-inc-cme-shares-bought-by-northpointe-capital-llc.html.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Further Reading: What is diluted earnings per share (Diluted EPS)?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.